Cresco Labs is trading 5.76% down at $0.62 amid cannabis-sector pressure tied to uncertainty over the paused federal marijuana-rescheduling hearing. - The DEA opposed reopening the hearing for more testimony and document discovery on October 22. - Latest located company updates concerned its October 30 shareholder meeting and November 6 results date. - Broader markets were also lower, adding risk-off context.